Ascendiant Capital Markets Cuts ENDRA Life Sciences (NASDAQ:NDRA) Price Target to $50.00
ENDRA Life Sciences (NASDAQ:NDRA – Get Free Report) had its target price reduced by investment analysts at Ascendiant Capital Markets from $75.00 to $50.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. ENDRA Life Sciences Price Performance NASDAQ:NDRA opened at $3.09 on Monday. The firm has […]
